NLS Pharmaceutics AG Net Income
| NLSPDelisted Stock | USD 7.62 0.08 1.04% |
As of the 13th of February 2026, NLS Pharmaceutics secures the Risk Adjusted Performance of (0.12), market risk adjusted performance of (2.20), and Mean Deviation of 5.08. In respect to fundamental indicators, the technical analysis model lets you check practical technical drivers of NLS Pharmaceutics, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from NLS Pharmaceutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NLS Pharmaceutics' valuation are summarized below:NLS Pharmaceutics AG does not now have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. NLS |
Search Suggestions
| NL | NL Industries | Company |
| NLY-PI | Annaly Capital Management | Company |
| NLCCX | Voya Large Cap Growth | Mutual Fund |
| NLR | VanEck UraniumNuclear Energy | ETF |
| NLG | NLG | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, NLS Pharmaceutics AG reported net income of (1.98 Million). This is 100.58% lower than that of the Biotechnology sector and 102.83% lower than that of the Health Care industry. The net income for all United States stocks is 100.35% higher than that of the company.
NLS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NLS Pharmaceutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NLS Pharmaceutics could also be used in its relative valuation, which is a method of valuing NLS Pharmaceutics by comparing valuation metrics of similar companies.NLS Pharmaceutics is currently under evaluation in net income category among its peers.
NLS Fundamentals
| Return On Equity | -8.63 | |||
| Return On Asset | -0.76 | |||
| Current Valuation | 10.18 M | |||
| Shares Outstanding | 5.21 M | |||
| Shares Owned By Insiders | 19.48 % | |||
| Shares Owned By Institutions | 5.89 % | |||
| Number Of Shares Shorted | 95.16 K | |||
| Price To Book | 4.84 X | |||
| EBITDA | (3.63 M) | |||
| Net Income | (1.98 M) | |||
| Cash And Equivalents | 1.35 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 826.76 K | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | 0.68 X | |||
| Cash Flow From Operations | (4.27 M) | |||
| Short Ratio | 0.12 X | |||
| Earnings Per Share | (17.40) X | |||
| Target Price | 6.0 | |||
| Beta | 0.13 | |||
| Market Capitalization | 3.97 M | |||
| Total Asset | 2.23 M | |||
| Retained Earnings | (74.43 M) | |||
| Working Capital | 1.4 M | |||
| Net Asset | 2.23 M |
About NLS Pharmaceutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NLS Pharmaceutics AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NLS Pharmaceutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NLS Pharmaceutics AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with NLS Pharmaceutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NLS Pharmaceutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will appreciate offsetting losses from the drop in the long position's value.Moving against NLS Stock
| 0.83 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
| 0.8 | DD | Dupont De Nemours | PairCorr |
| 0.77 | CAT | Caterpillar | PairCorr |
| 0.73 | HD | Home Depot Sell-off Trend | PairCorr |
| 0.69 | PG | Procter Gamble | PairCorr |
The ability to find closely correlated positions to NLS Pharmaceutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NLS Pharmaceutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NLS Pharmaceutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NLS Pharmaceutics AG to buy it.
The correlation of NLS Pharmaceutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NLS Pharmaceutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NLS Pharmaceutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NLS Pharmaceutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in NLS Stock
If you are still planning to invest in NLS Pharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NLS Pharmaceutics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |